Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Change in Receivables: 2021-2025

Historic Change in Receivables for Biofrontera (BFRI) over the last 5 years, with Sep 2025 value amounting to -$947,000.

  • Biofrontera's Change in Receivables fell 167.45% to -$947,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.9 million, marking a year-over-year decrease of 262.16%. This contributed to the annual value of $315,000 for FY2024, which is 79.49% down from last year.
  • As of Q3 2025, Biofrontera's Change in Receivables stood at -$947,000, which was down 976.14% from -$88,000 recorded in Q2 2025.
  • Over the past 5 years, Biofrontera's Change in Receivables peaked at $2.2 million during Q4 2022, and registered a low of -$3.1 million during Q2 2022.
  • Over the past 3 years, Biofrontera's median Change in Receivables value was -$5,000 (recorded in 2024), while the average stood at -$46,727.
  • In the last 5 years, Biofrontera's Change in Receivables tumbled by 30,900.00% in 2022 and then skyrocketed by 467.68% in 2023.
  • Biofrontera's Change in Receivables (Quarterly) stood at $1.8 million in 2021, then grew by 19.70% to $2.2 million in 2022, then tumbled by 38.93% to $1.3 million in 2023, then crashed by 63.06% to $492,000 in 2024, then slumped by 167.45% to -$947,000 in 2025.
  • Its last three reported values are -$947,000 in Q3 2025, -$88,000 for Q2 2025, and -$1.3 million during Q1 2025.